| HL60 cells |
Function assay |
10 μM |
48 h |
JSH-23 (10 μM) obviously decreased NF-κB DNA binding activity |
30125548 |
| BMDM |
Function assay |
60 μM |
19-24 h |
JSH-23 (60 μM) induced a decrease of IL-1β release |
30138321 |
| MCF-7:2A |
Function assay |
20 μmol/L |
3 and 6 days |
JSH-23 increased E2-induced apoptosis in MCF-7:2A cells |
30224430 |
| MCF-7:5C |
Function assay |
20 μmol/L |
3 and 6 days |
JSH-23 completely blocked E2-induced apoptosis in MCF-7:5C cells |
30224430 |
| HK-2 cells |
Function assay |
100?μM |
3?h |
pretreatment with JSH-23 effectively blocked Ang II-induced nuclear p65 accumulation |
30874544 |
| BV2 cells |
Function assay |
30 μM |
1 h |
pretreatment of JSH-23 decreased the levels of IL-6 and NO production in LPS-stimulated microglia. |
29890414 |
| A549 cells |
Cell viability assay |
5, 10, 20, 30, 40 and 50 μM |
24 h |
with the increase in JSH-23 concentration, the inhibition rate for cell viability was gradually increased, and significant differences existed when the JSH-23 concentration was greater than 20 μM. |
28281961 |
| U2OS/DR-GFP cells |
Function assay |
10 and 20 μM |
|
JSH-23 treatment significantly decreased the HR frequency |
30770924 |